ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%
Thu, 23 Jan

ALEMBIC PHARMA has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m10,18212,40912,091-2.6%18.8%
Other incomeRs m354413.3%-88.4%
TurnoverRs m10,21712,41212,095-2.6%18.4%
ExpensesRs m7,7598,9548,841-1.3%13.9%
Gross profitRs m2,4223,4553,251-5.9%34.2%
DepreciationRs m29136041816.3%44.0%
InterestRs m6071744.1%23.8%
Profit before taxRs m2,1083,0292,763-8.8%31.1%
TaxRs m400525486-7.4%21.5%
Profit after taxRs m1,7082,5042,277-9.1%33.3%
Gross profit margin%23.827.826.9
Effective tax rate%19.017.317.6
Net profit margin%16.720.218.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 18.8% on a year-on-year (YoY) basis. The expenses were up by 13.9% YoY during the same period.
  • The company's operating profit increased by 34.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.9% in 3QFY20 as against 23.8% in 3QFY19.
  • Depreciation charges increased by 44.0% and finance costs increased by 23.8% YoY, respectively.
  • Other income declined by 88.4% YoY during the quarter.
  • Net profit for the quarter increased by 33.3% YoY. Net profit margins during the quarter increased from 16.7% in 3QFY19 to 18.8% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 2.6% on a quarter-on-quarter (QoQ) basis. The expenses were down by 1.3% QoQ during the same period.
  • The company's operating profit declined by 5.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 26.9% in 3QFY20 as against 27.8% in 2QFY19.
  • Net profit for the quarter declined by 9.1% QoQ, while net profit margins declined from 20.2% in 2QFY19 to 18.8% in 3QFY20.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

ENDING SOON: Discover Our Top 7 Stocks for 2020 Virtually FREE till 11:59pm TODAY Only!

ALEMBIC PHARMA Share Price Performance

Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 592.0 to Rs 587.0, registering a Loss of Rs 5.0 or around 0.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,048.8 (up 0.3%). Over the last one year it has moved down from 14,066.6 to 14,048.8, a gain of 18 points (down 0.1%).

Overall, the S&P BSE SENSEX is up 13.4% over the year.

Current Valuations

At the current price of Rs 587.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.1 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today(Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 28, 2020 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS